Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary disease

Thorax

Volumn 65, Issue 1, 2010, Pages 85-90

  Hurst, J R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RHINITIS; CIGARETTE SMOKING; DISEASE EXACERBATION; DISEASE SEVERITY; FLORA; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; INFLAMMATION; LAVAGE; LOWER RESPIRATORY TRACT; MUCOCILIARY CLEARANCE; NOSE; NOSE CONGESTION; NOSE SECRETION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SINUSITIS; SMELLING DISORDER; SNEEZING; SPIROMETRY; TREATMENT FAILURE; UPPER RESPIRATORY TRACT; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 73449125469     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.112888     Document Type: Review

References (36)

1. Global Strategy for Diagnosis, Management and Prevention of COPD. Available at: http://www.goldcopd.com/GuidelinesResources.asp (accessed 7 Apr 2009).
2. Phillips DE, Hill L, Weller P, et al. Tobacco smoke and the upper airway. Clin Otolaryngol Allied Sci 2003;28:492-6.
3. Benninger MS. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinol 1999;13:435-8.
4. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). Ann Allergy 1991;67:147-54.
5. Annesi-Maesano I, Oryszczyn MP, Neukirch F, et al. Relationship of upper airway disease to tobacco smoking and allergic markers: a cohort study of men followed up for 5 years. Int Arch Allergy Immunol 1997;114:193-201.
6. Stanley PJ, Wilson R, Greenstone MA, et al. Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 1986;41:519-23.
7. Dessi P, Sambuc R, Moulin G, et al. Effect of heavy smoking on nasal resistance. Acta Otolaryngol 1994;114:305-10.
8. Montnemery P, Svensson C, Adelroth E, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596-603.
9. Nihlen U, Montnemery P, Andersson M, et al. Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD. Clin Physiol Funct Imaging 2008;28:240-50.
10. van Manen JG, Bindels PJE, Ijzermans CJ, et al. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287-93.
11. Roberts NJ, Lloyd-Owen SJ, Rapado F, et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med 2003;97:909-14.
12. Sichletidis L, Tsiotsios I, Gavriilidis A, et al. Prevalence of chronic obstructive pulmonary disease and rhinitis in Northern Greece. Respiration 2005;72:270-7.
13. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38:260-75.
14. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 2003;129(Suppl):S1-32.
15. Nihlen U, Andersson M, Lofdahl CG, et al. Nasal neutrophil activity and mucinous secretory responsiveness in COPD. Clin Physiol Funct Imaging 2003;23:138-42.
16. Hurst JR, Wilkinson TM, Perera WR, et al. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest 2005;127:1219-26.
17. de Smet AM, Kluytmans JAJW, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
18. Hens G, Vanaudenaerde BM, Bullens DMA, et al. Sinonasal pathology in nonallergic asthma and COPD: "united airway disease" beyond the scope of allergy. Allergy 2008;63:261-7.
19. Vachier I, Vignola AM, Chiappara G, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004;59:303-7.
20. Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 2004;18:15-21.
21. Ragab A, Clement P, Vincken W. Correlation between the cytology of the nasal middle meatus and BAL in chronic rhinosinusitis. Rhinology 2005;43:11-7.
22. Hurst JR, Perera WR, Wilkinson TM, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71-8.
23. Mallia P, Message SD, Kebadze T, et al. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res 2006;7:116.
24. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
25. Hurst JR, Donaldson GC, Wilkinson TM, et al. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 2005;26:846-52.
26. Hurst JR, Kuchai R, Michael P, et al. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease. Clin Physiol Funct Imaging 2006;26:251-6.
27. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469-76.
28. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-65.
29. Sarin S, Undem B, Sanico A, et al. The role of the nervous system in rhinitis. J Allergy Clin Immunol 2006;118:999-1016.
30. Hurst JR, Wilkinson TM, Donaldson GC, et al. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respir Med 2004;98:767-70.
31. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD. Factors associated with poor treatment outcome. Chest 2000;117:662-71.
32. McDougall CM, Blaylock MG, Douglas JG, et al. Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 2008;39:560-8.
33. Devalia JL, Sapsford RJ, Wells CW, et al. Culture and comparison of human bronchial and nasal epithelial cells in vitro. Respir Med 1990;84:303-12.
34. Sridhar S, Schembri F, Zeskind J, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 2008;9:259.
35. Karatzanis AD, Samara KD, Tzortzaki E, et al. Microsatellite DNA instability in nasal cytology of COPD patients. Oncol Rep 2007;17:661-5.
36. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006;118(Suppl):S17-61.